Administration of an antagonist of a5ß1 for anti-angiogenesis and cancer treatment

• 收藏
• 分享

专利权人:

Xiaodong Feng

发明人:

Xiaodong Feng

申请号：

US13374369

公开号：

US20130165380A1

申请日:

2011.12.22

申请国别(地区):

US

年份:

2013

代理人:

摘要：

The teachings provided herein generally relate to a combination therapy and are directed to pharmaceutical compositions and methods for administering a combination of an a5β1 antagonist with an a2β1 antagonist to a subject. The methods are for use in inhibiting, preventing, or reversing angiogenesis, as well as in treating cancer. In some embodiments, the compositions and methods include a combined administration of VLO4 and VP12 (ECL12).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/